Mersana Therapeutics Inc (MRSN)
2.725
+0.14
(+5.62%)
USD |
NASDAQ |
May 17, 16:00
2.725
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Revenue (TTM): 38.30M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 38.30M |
| December 31, 2023 | 36.86M |
| September 30, 2023 | 40.84M |
| June 30, 2023 | 38.72M |
| March 31, 2023 | 32.35M |
| December 31, 2022 | 26.58M |
| September 30, 2022 | 11.90M |
| June 30, 2022 | 6.342M |
| March 31, 2022 | 2.069M |
| December 31, 2021 | 0.044M |
| September 30, 2021 | 0.044M |
| June 30, 2021 | 0.044M |
| March 31, 2021 | 0.829M |
| December 31, 2020 | 0.829M |
| September 30, 2020 | 0.86M |
| Date | Value |
|---|---|
| June 30, 2020 | 1.693M |
| March 31, 2020 | 1.099M |
| December 31, 2019 | 42.12M |
| September 30, 2019 | 43.27M |
| June 30, 2019 | 44.58M |
| March 31, 2019 | 48.57M |
| December 31, 2018 | 10.60M |
| September 30, 2018 | 12.67M |
| June 30, 2018 | 16.78M |
| March 31, 2018 | 16.32M |
| December 31, 2017 | 17.54M |
| September 30, 2017 | 26.28M |
| June 30, 2017 | 23.28M |
| March 31, 2017 | 25.76M |
| December 31, 2016 | 25.17M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.044M
Minimum
Jun 2021
44.58M
Maximum
Jun 2019
18.47M
Average
9.123M
Median
Revenue (TTM) Benchmarks
| Amicus Therapeutics Inc | 423.49M |
| Geron Corp | 0.52M |
| Insmed Inc | 315.49M |
| Altimmune Inc | 0.41M |
| InfuSystems Holdings Inc | 127.41M |